Share on StockTwits
 

Questcor Pharmaceuticals (NASDAQ:QCOR) Insider David Young sold 6,000 shares of Questcor Pharmaceuticals stock on the open market in a transaction dated Friday, January 24th. The stock was sold at an average price of $64.38, for a total value of $386,280.00. Following the sale, the insider now directly owns 91,145 shares of the company’s stock, valued at approximately $5,867,915. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

A number of analysts have recently weighed in on QCOR shares. Analysts at Zacks reiterated a “neutral” rating on shares of Questcor Pharmaceuticals in a research note to investors on Friday. They now have a $68.00 price target on the stock. Separately, analysts at Mizuho reiterated a “buy” rating on shares of Questcor Pharmaceuticals in a research note to investors on Tuesday, November 26th. Three analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $77.00.

Questcor Pharmaceuticals (NASDAQ:QCOR) traded up 1.84% during mid-day trading on Tuesday, hitting $64.18. The stock had a trading volume of 1,881,276 shares. Questcor Pharmaceuticals has a 1-year low of $24.75 and a 1-year high of $74.76. The stock’s 50-day moving average is $55.74 and its 200-day moving average is $59.8. The company has a market cap of $3.779 billion and a price-to-earnings ratio of 14.47.

Questcor Pharmaceuticals, Inc (NASDAQ:QCOR) is a biopharmaceutical company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.